Insights On Upstream Manufacturing
-
Innovating Upstream Manufacturing For The Next Wave Of Gene Therapies
3/4/2026
Explore a streamlined approach to transient AAV production, including yield improvements across serotypes, key transfection parameters, and practical guidance for scaling processes.
-
Mesenchymal Stromal Cells: The Progress And Manufacturing Challenges
2/27/2026
Understand the manufacturing challenges where rapid cell expansion often conflicts with therapeutic secretion profiles, requiring sophisticated quality control and donor selection strategies.
-
Getting Your Proof Of Clonality Right For Regulators
2/27/2026
Regulators require clear, verifiable proof that production cell lines originate from a single progenitor cell, supported by strong imaging, documentation, and data integrity to ensure product consistency and safety.
-
What Makes A Cell Bank 'GMP-Ready'?
2/27/2026
A GMP‑ready cell bank requires controlled stability, sterility, genetic integrity, and complete documentation to ensure consistent, safe biologic production and meet regulatory expectations.
-
CHO Cell Line Performance With 2G UNic® Technology
2/27/2026
Optimized vector designs significantly enhance CHO cell protein expression, yielding higher titers, better stability, and strong performance across diverse host lines and scale‑up stages.
-
How Early Data Drives Better Cell Line Performance
2/27/2026
Structured early data strengthens clonality assurance, stability, and tech transfer, supporting consistent performance, lower variability, and smoother progression to manufacturing.
-
A Journey To Produce MSC-Derived Cell Therapies From Isolation To Large-Scale
2/26/2026
Drive successful MSC therapy development by optimizing isolation methods, surface chemistry, and closed-system expansion technologies to ensure cellular stability and commercial scalability.
-
Scaling MSC Therapies: Overcoming Cell Therapy Manufacturing Risks And Barriers
2/26/2026
Achieve scalable MSC manufacturing by implementing closed systems and modular scale-out strategies that minimize contamination risks and ensure consistent cellular stability and efficacy.
-
Laboratory Cell Line Development
2/24/2026
Efficient cell line development demands reliable clone selection and early removal of candidates. Filtration and sample prep solutions can strengthen sterility, simplify workflows, and support decisions.
-
9 Considerations When Buying Used Laboratory Equipment
2/24/2026
Before purchasing used lab equipment, evaluate contamination risks, service history, and manufacturer support. Ensure short-term savings do not compromise your long-term research reliability.